The Liver Meeting 2020-A Conversation with the Newest Nobel Laureates

Video Transcription

Video Summary

In a special session of the ASLD meeting, Drs. Alter, Houghton, and Rice shared insights on their Nobel Prize-winning work in identifying and advancing research on the hepatitis C virus. Dr. Alter's groundbreaking research on transfusion-related hepatitis led to the discovery of the non-A, non-B hepatitis virus. Dr. Houghton's work on recombinant DNA technology helped isolate the hepatitis C virus genome, enabling the development of blood tests and antiviral agents. Dr. Rice's genetic engineering studies confirmed the causative agent of non-A, non-B hepatitis. They discussed the future of hep C research, emphasizing the importance of a vaccine for global eradication and the need for affordable treatments and efficient testing strategies. Their association with ASLD has provided a platform for collaboration and knowledge exchange, enriching their legacy in hep C research. The session concluded with a poetic tribute by Dr. Alter, highlighting the journey and camaraderie in scientific discovery. Their dedication to advancing hep C research leaves a lasting impact on the field's progress and future possibilities.

Keywords

ASLD meeting

Dr. Alter

Dr. Houghton

Dr. Rice

Nobel Prize

hepatitis C virus

transfusion-related hepatitis

recombinant DNA technology

genetic engineering

vaccine development